Mandar V. Dali

Person

New Brunswick, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclo...
- Patent number 11,786,486
- Issue date Oct 17, 2023
- PTC Therapeutics, Inc.
- Swathi Pinnamaneni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic...
- Patent number 10,618,877
- Issue date Apr 14, 2020
- PTC Therapeutics, Inc.
- Marla L. Weetall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic...
- Patent number 10,233,161
- Issue date Mar 19, 2019
- PTC Therapeutics, Inc.
- Marla L. Weetall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic...
- Patent number 9,873,677
- Issue date Jan 23, 2018
- PTC Therapeutics, Inc.
- Marla L. Weetall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent number 9,198,925
- Issue date Dec 1, 2015
- Astrazeneca AB
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent number 8,716,251
- Issue date May 6, 2014
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent number 8,361,972
- Issue date Jan 29, 2013
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent number 8,221,786
- Issue date Jul 17, 2012
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent number 7,851,502
- Issue date Dec 14, 2010
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Patent number 7,659,261
- Issue date Feb 9, 2010
- Bristol-Myers Squibb Co.
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...
- Patent number 7,659,262
- Issue date Feb 9, 2010
- Bristol-Myers Squibb Co.
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Patent number 7,524,832
- Issue date Apr 28, 2009
- Bristol-Myers Squibb Co.
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Patent number 6,855,702
- Issue date Feb 15, 2005
- Bristol-Myers Squibb Company
- John J. Venit
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...
- Patent number 6,670,344
- Issue date Dec 30, 2003
- Bristol-Myers Squibb Company
- John J. Venit
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,5-TRIMETHYL-6-NONYLCYCLO...
- Publication number 20240000725
- Publication date Jan 4, 2024
- PTC THERAPEUTICS, INC.
- Swathi PINNAMANENI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKIN...
- Publication number 20230405000
- Publication date Dec 21, 2023
- PTC THERAPEUTICS, INC.
- Swathi Pinnamaneni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,5-TRIMETHYL-6-NONYLCYCLO...
- Publication number 20230022538
- Publication date Jan 26, 2023
- PTC THERAPEUTICS, INC.
- Swathi PINNAMANENI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF
- Publication number 20220185795
- Publication date Jun 16, 2022
- PTC THERAPEUTICS, INC.
- Akm Nasir Uddin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DISPERSIBLE TABLET COMPOSITION
- Publication number 20220175800
- Publication date Jun 9, 2022
- PTC Therapeutics Inc.
- Akm Nasir Uddin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOAVAILABLE ORAL DOSAGE FORMS
- Publication number 20210205225
- Publication date Jul 8, 2021
- PTC THERAPEUTICS, INC.
- Mandar V. DALI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS AND SALTS OF A 1,2,4-OXADIAZOLE BENZOIC...
- Publication number 20190152931
- Publication date May 23, 2019
- PTC THERAPEUTICS, INC.
- Marla L. WEETALL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITIONS AND SALTS OF A 1,2,4-OXADIAZOLE BENZOIC...
- Publication number 20180179170
- Publication date Jun 28, 2018
- PTC THERAPEUTICS, INC.
- Marla L. WEETALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS AND SALTS OF A 1,2,4-OXADIAZOLE BENZOIC...
- Publication number 20170066730
- Publication date Mar 9, 2017
- PTC THERAPEUTICS, INC.
- Marla L. WEETALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS CONTAINING AN SGLT2 INHIBITOR
- Publication number 20140243262
- Publication date Aug 28, 2014
- AstraZeneca AB
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulations Containing An SGLT2 Inhibitor
- Publication number 20130129819
- Publication date May 23, 2013
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulations Containing an SGLT2 Inhibitor
- Publication number 20120263786
- Publication date Oct 18, 2012
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulations Containing an SGLT2 Inhibitor
- Publication number 20110064801
- Publication date Mar 17, 2011
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 Phosphate Prodrug Mono- and Di- Organic Amine Sa...
- Publication number 20090186857
- Publication date Jul 23, 2009
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATION CONTAINING AN SGLT2 INHIBITOR
- Publication number 20080234366
- Publication date Sep 25, 2008
- Bristol-Myers Squibb
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...
- Publication number 20070270617
- Publication date Nov 22, 2007
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20060172980
- Publication date Aug 3, 2006
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20060166942
- Publication date Jul 27, 2006
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20060165772
- Publication date Jul 27, 2006
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20050153939
- Publication date Jul 14, 2005
- Bristol-Myers Squibb Company
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20020072507
- Publication date Jun 13, 2002
- John J. Venit
- C07 - ORGANIC CHEMISTRY

Mandar V. Dali

Person

Patents Grantslast 30 patents

Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclo...

Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic...

Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic...

Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic...

Pharmaceutical formulations containing an SGLT2 inhibitor

Pharmaceutical formulations containing an SGLT2 inhibitor

Pharmaceutical formulations containing an SGLT2 inhibitor

Pharmaceutical formulations containing an SGLT2 inhibitor

Pharmaceutical formulations containing an SGLT2 inhibitor

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...

Patents Applicationslast 30 patents

PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,5-TRIMETHYL-6-NONYLCYCLO...

TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKIN...

PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,5-TRIMETHYL-6-NONYLCYCLO...

COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF

DISPERSIBLE TABLET COMPOSITION

BIOAVAILABLE ORAL DOSAGE FORMS

PHARMACEUTICAL COMPOSITIONS AND SALTS OF A 1,2,4-OXADIAZOLE BENZOIC...

PHARMACEUTICAL COMPOSITIONS AND SALTS OF A 1,2,4-OXADIAZOLE BENZOIC...

PHARMACEUTICAL COMPOSITIONS AND SALTS OF A 1,2,4-OXADIAZOLE BENZOIC...

PHARMACEUTICAL FORMULATIONS CONTAINING AN SGLT2 INHIBITOR

Pharmaceutical Formulations Containing An SGLT2 Inhibitor

Pharmaceutical Formulations Containing an SGLT2 Inhibitor

Pharmaceutical Formulations Containing an SGLT2 Inhibitor

Combretastatin A-4 Phosphate Prodrug Mono- and Di- Organic Amine Sa...

PHARMACEUTICAL FORMULATION CONTAINING AN SGLT2 INHIBITOR

Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...